{
    "code": "02025217",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025217",
    "time": "2016-12-30 03:27:45",
    "許可證字號": "衛署藥輸字第025217號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "109\/06\/15",
    "發證日期": "99\/06\/15",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202521703",
    "中文品名": "瑞復美膠囊5毫克",
    "英文品名": "Revlimid Capsules 5mg",
    "適應症": "1. Revlimid與dexamethasone合併使用可治療先前已接受至少一種治療失敗之多發性骨髓瘤(multiple myeloma, MM)患者。\r\n2. Revlimid可治療先前尚未接受過任何治療且不適合移植之成年患者",
    "劑型": "130膠囊劑",
    "包裝": "2-1000粒以下鋁箔盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "LENALIDOMIDE"
    ],
    "限制項目": "02輸　入 1D須執行風險管理計畫 1EPhase IV Study",
    "申請商名稱": "620117G076  賽基有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F430247000  CELGENE INTERNATIONAL SARL",
        "製造廠廠址": "ROUTE DE PERREUX 1 2017 BOUDRY SWITZERLAND",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F390036000  BOLLORE LOGISTICS SINGAPORE PTE. LTD.",
            "製造廠廠址": "101 ALPS AVENUE #03-01 SINGAPORE 498793",
            "製造廠公司地址": "",
            "製造廠國別": "SINGAPORE",
            "製程": ""
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1008200300",
            "成分名稱": "LENALIDOMIDE",
            "含量描述": "",
            "含量": "5.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "中文仿單(4劑量共用)-105-04-19.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025217&Seq=009&Type=9"
        },
        {
            "title": "020252170001-2014-03-03.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025217&Seq=008&Type=9"
        },
        {
            "title": "REVLIMID_FDA_PI_0109___20110712.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025217&Seq=007&Type=9"
        },
        {
            "title": "REVLIMID_FDA_PI_0109(1)___20110712.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025217&Seq=006&Type=9"
        },
        {
            "title": "Revlimid RLM-L-0109-1031___20120216.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025217&Seq=005&Type=9"
        },
        {
            "title": "Revlimid leaflet -Celgene___20111104.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025217&Seq=004&Type=9"
        },
        {
            "title": "L___20110712.v02_MM-TW.PDF",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025217&Seq=003&Type=9"
        },
        {
            "title": "9908-Revlimid RLM-L-0109 (10004仿單修正後)___20110712.doc",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025217&Seq=002&Type=9"
        },
        {
            "title": "020252170001___20100909.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025217&Seq=001&Type=9"
        },
        {
            "title": "外盒中文小標籤_ 5毫克-105-04-19.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025217&Seq=003&Type=8"
        },
        {
            "title": "Label-C v01_REV05-TW___20110712.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025217&Seq=002&Type=8"
        },
        {
            "title": "020252170001___20100909.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025217&Seq=001&Type=8"
        }
    ]
}